| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +53% |
| 3Y CAGR | +61% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +96% |
| 3Y CAGR | +155% |
| Fund name | AUM% |
|---|---|
| 0.78 |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,903.90 -15.60 (0.32%) | 22,495.76 | 30.6 | 5.35 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,550.10 -20.90 (0.81%) | 19,542.61 | 28.82 | 5.45 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,542.50 +42.00 (0.56%) | 18,770.50 | 110.66 | 21.51 | ||
Natco PharmaNATCOPHARM | ₹892.30 +6.95 (0.79%) | 15,887.94 | 13.88 | 1.72 |